Apollon Wealth Management LLC Sells 6,931 Shares of Unilever PLC (NYSE:UL)

Apollon Wealth Management LLC decreased its stake in shares of Unilever PLC (NYSE:UL) by 15.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 38,979 shares of the company’s stock after selling 6,931 shares during the period. Apollon Wealth Management LLC’s holdings in Unilever were worth $2,532,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Empowered Funds LLC acquired a new stake in shares of Unilever in the 1st quarter valued at $684,000. Orion Portfolio Solutions LLC boosted its holdings in Unilever by 12.6% in the first quarter. Orion Portfolio Solutions LLC now owns 153,137 shares of the company’s stock valued at $7,686,000 after acquiring an additional 17,094 shares during the last quarter. Dorsey & Whitney Trust CO LLC increased its position in Unilever by 1.4% in the first quarter. Dorsey & Whitney Trust CO LLC now owns 20,154 shares of the company’s stock worth $1,012,000 after purchasing an additional 282 shares during the period. Motco raised its holdings in Unilever by 1.5% during the 1st quarter. Motco now owns 97,880 shares of the company’s stock worth $4,913,000 after purchasing an additional 1,404 shares during the last quarter. Finally, Pinkerton Retirement Specialists LLC lifted its position in Unilever by 49.6% during the 1st quarter. Pinkerton Retirement Specialists LLC now owns 74,981 shares of the company’s stock valued at $3,763,000 after purchasing an additional 24,845 shares during the period. Institutional investors own 9.67% of the company’s stock.

Unilever Stock Performance

Shares of NYSE:UL opened at $57.39 on Thursday. The company has a 50 day moving average price of $63.06 and a two-hundred day moving average price of $59.33. The company has a market capitalization of $142.87 billion, a PE ratio of 16.98, a PEG ratio of 1.74 and a beta of 0.49. Unilever PLC has a 52 week low of $46.46 and a 52 week high of $65.87.

Unilever Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 8th will be given a $0.4755 dividend. The ex-dividend date of this dividend is Friday, November 8th. This represents a $1.90 dividend on an annualized basis and a dividend yield of 3.31%. This is a boost from Unilever’s previous quarterly dividend of $0.35. Unilever’s dividend payout ratio is currently 55.62%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on the stock. Bank of America upgraded shares of Unilever from an “underperform” rating to a “buy” rating and lifted their price target for the stock from $47.00 to $72.00 in a research report on Thursday, August 22nd. TD Cowen initiated coverage on shares of Unilever in a report on Tuesday, July 23rd. They set a “buy” rating and a $67.00 target price for the company. StockNews.com downgraded Unilever from a “buy” rating to a “hold” rating in a research note on Tuesday. Finally, UBS Group raised Unilever to a “strong sell” rating in a research note on Tuesday, July 30th. Three investment analysts have rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $61.75.

Unilever Profile

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.